<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01387477</url>
  </required_header>
  <id_info>
    <org_study_id>IAAM 2011-01</org_study_id>
    <nct_id>NCT01387477</nct_id>
  </id_info>
  <brief_title>Lactate and Hypoglycemia</brief_title>
  <official_title>Comparison of Two Strategies of Hypoglycemia Correction in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut d'Anesthesiologie des Alpes Maritimes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut d'Anesthesiologie des Alpes Maritimes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tight glucose control in intensive care has become a major concern, allowing a reduction in
      morbidity and mortality. However, its use is limited by the percentage of hypoglycemia which
      can have severe consequences on the brain. The bispectral index (BIS) is derived from the EEG
      and measures of brain electrical activity noninvasively. It has already been shown that its
      value changes according to hypoglycemia and its correction. Furthermore, if the hormonal
      response to hypoglycemia is well known in healthy and diabetic subjects, it is not the case
      in ICU patient. The usual treatment of hypoglycemia is based on parenteral infusion of
      glucose. Btu this can lead to a hyperglycemic rebound that can be deleterious. Lactate is a
      substrate for gluconeogenesis and an energy substrate during critical situations. It has been
      shown to improve neurological tests during hypoglycaemia and had cerebral protective
      properties after a severe head injury. The hypothesis of this study is that sodium lactate is
      superior than the 30% glucose to correct hypoglycemia in the ICU in terms of glycemic
      variation, brain function and hormonal response.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the curve of the glycemia</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bispectral index variation</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum change in glycemia</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in growth hormone and cortisol</measure>
    <time_frame>180 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for glucose infusion for persistent hypoglycemia</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>Lactate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infusion of 66 mmol of lactate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>glucose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infusion of 33 mmol of glucose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactate</intervention_name>
    <description>Infusion of 66 mmol of lactate</description>
    <arm_group_label>Lactate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glucose</intervention_name>
    <description>Infusion of 33 mmol of glucose</description>
    <arm_group_label>glucose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hypoglycemia under 0.6 g/L

        Exclusion Criteria:

          -  hepatic failure

          -  hyperlactatemia above 5 mmol/L
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Christophe Orban, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nice University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Christophe Orban, MD</last_name>
    <email>orban.jc@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Réanimation médico-chirurgicale</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Christophe Orban, MD</last_name>
      <email>orban.jc@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2011</study_first_submitted>
  <study_first_submitted_qc>July 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2011</study_first_posted>
  <last_update_submitted>July 1, 2011</last_update_submitted>
  <last_update_submitted_qc>July 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Jean-Christophe Orban</name_title>
    <organization>Carole Ichai</organization>
  </responsible_party>
  <keyword>hypoglycemia</keyword>
  <keyword>lactate</keyword>
  <keyword>glucose</keyword>
  <keyword>ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

